Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma

Betta Pharmaceuticals Co., Ltd. · 2012
ClinicalTrials.gov · Datasets · License: Public Domain · 2012
Open Source ↗
firstsmallcelllungcancer
egfr positive non-small cell lung cancer, adenocarcinoma, icotinib, egfr positive mutation, first-line treatment, maintenance treatment, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 894925
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.